Archive
2019, Volume 3
2018, Volume 2
2017, Volume 1




Volume 3, Issue 1, June 2019, Page: 17-22
Contribution, Indications and Technical Realization of Ultrasound-guided Liver Biopsy
Fatma Daoud, Internal Medicine and Rheumatology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Mehdi Somai, Internal Medicine and Rheumatology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Ines Ben Hassen, Radiology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Imene Rachdi, Internal Medicine and Rheumatology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Dorra Trad, Gastroenterology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Sarra Bejaoui, Radiology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Raja Jouini, Anatomopathology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Hana Zoubeidi, Internal Medicine and Rheumatology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Ehsen Ben Brahim, Anatomopathology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Dalila Gargouri, Gastroenterology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Mohamed Habib Daghfous, Radiology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Achraf Chedli-Debbiche, Anatomopathology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Fatma Boussema, Internal Medicine and Rheumatology Department, Habib Thameur Hospital, Tunis El Manar University, Tunis, Tunisia
Received: Jul. 24, 2019;       Accepted: Aug. 14, 2019;       Published: Aug. 28, 2019
DOI: 10.11648/j.ijg.20190301.13      View  33      Downloads  4
Abstract
The liver biopsy (LB) still keeps some indications today, in spite of the progress of the non-invasive explorations. Several LB techniques have been studied. Some techniques use medical imaging. These techniques also differ in the material used to collect the hepatic sample. This study aimed to determine the current indications of LB, the interest using ultrasound guidance and an automatic device in order to improve its performance and its contribution to the diagnosis. This was a retrospective study including percutaneous LB performed under ultrasound guidance using automatic system equipped with a sharp needle. The study involved 50 patients with 26 diffuse liver diseases (DLD) and 24 focal liver lesions (FLL). The indications for DLD biopsy were dominated by suspicion of hepatic sarcoidosis, primary biliary cirrhosis and hepatic tuberculosis. FLL were dominated by the exploration of nodules or masses. The number of passes made was three in 96% of cases, otherwise it was four, with an average size of 1.3 cm for cores. DLD were dominated by chronic liver disease (42%), granulomatous hepatitis (23%), steatohepatitis (11%) and primary biliary cirrhosis (8%). FLL were dominated by secondary malignancies (46%) and primary malignant lesions (25%). For FLL, LB sensitivity, specificity, positive predictive value and negative predictive value were respectively 81%, 100%, 100% and 20%. LB confirmed 45% of DLD diagnoses, when they were well oriented by clinical and paraclinical data. The LB allowed to rectify the diagnosis in 54% of cases. When no initial diagnosis was suspected, LB enabled a specific diagnosis in 75% of cases. Major complications were void in our study. In conclusion, the use of ultrasound guidance and an automatic device with a sharp needle has increased the number of passes, improved the quality of sampling and reduced complications.
Keywords
Focal Liver Lesions, Diffuse Liver Disease, Biopsy, Ultrasound, Contribution
To cite this article
Fatma Daoud, Mehdi Somai, Ines Ben Hassen, Imene Rachdi, Dorra Trad, Sarra Bejaoui, Raja Jouini, Hana Zoubeidi, Ehsen Ben Brahim, Dalila Gargouri, Mohamed Habib Daghfous, Achraf Chedli-Debbiche, Fatma Boussema, Contribution, Indications and Technical Realization of Ultrasound-guided Liver Biopsy, International Journal of Gastroenterology. Vol. 3, No. 1, 2019, pp. 17-22. doi: 10.11648/j.ijg.20190301.13
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Degos F, Degott C, Benhamou J. Biopsie hépatique. Med Sci. 1993: 320-3.
[2]
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009; 49: 1017-44.
[3]
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000; 32: 477-81.
[4]
Berger D, Desai V, Janardhan S. Liver biopsy remains the gold standard to evaluate fibrosis in patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2019 Apr; 13 (4): 114–116.
[5]
Tapper EB, Lok AS. Use of Liver Imaging and Biopsy in Clinical Practice. N Engl J Med. 2017 Aug 24; 377 (8): 756-768.
[6]
Cadranel JF, Nousbaum JB. [Current trends in liver biopsy indications in chronic liver diseases]. Presse medicale. 2012; 41 (11): 1064-70.
[7]
Cadranel JF, Nousbaum JB, Hanslik B. ANGH, AFEF, CREGG. Major trends in liver biopsy practices in France: results of a national multicentre survey in 2009 and comparison with 1997. J Hepatol 2011; 54: S137.
[8]
Joly JP, Capron D. La pratique de la ponction-biopsie hépatique peut-elle être standardisée. Gastroenterol Clin Biol 2001; 25: 71-2.
[9]
Bateson M, Hopwood D, Duguid H, Bouchier I. A comparative trial of liver biopsy needles. J Clin Pathol. 1980; 33: 131-3.
[10]
Festorazzi S. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology. 1988; 95: 487-9.
[11]
Piccinino F, Sagnelli E, Pasquale G, Giusti G, Battocchia A, Bernardi M, et al. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. J hepatol. 1986; 2: 165-73.
[12]
Yu SC, Lau W, Leung W, Liew C, Leung N, Metreweli C. Percutaneous biopsy of small hepatic lesions using an 18 gauge automated needle. Br J Radiol. 1998; 71: 621-4.
[13]
Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology. 1978; 74: 103-6.
[14]
Gilmore I, Burroughs A, Murray-Lyon I, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut. 1995; 36: 437-41.
[15]
Froehlich F, Lamy O, Fried M, Gonvers J. Practice and complications of liver biopsy. Digest Dis Sci. 1993; 38: 1480-4.
[16]
Chevallier P, Ruitort F, Denys A, Staccini P, Saint-Paul MC, Ouzan D, et al. Influence of operator experience on performance of ultrasound-guided percutaneous liver biopsy. Eur Radiol. 2004; 14 (11): 2086-91.
[17]
Spengler U, Fischer H. Liver biopsy at the intersection of clinical and pathological diagnosis. Der Pathologe. 2008; 29: 6-14.
[18]
Eskandari A, Koo P, Bang H, Gui D, Urayama S. Comparison of Endoscopic Ultrasound Biopsy Needles for Endoscopic Ultrasound-Guided Liver Biopsy. Clin Endosc. 2019 Jul; 52 (4): 347-352.
[19]
Nousbaum JB, Cadranel JF, Bonnemaison G, Bourliere M, Chiche L, Chor H, et al. Recommandations pour la pratique clinique pour la réalisation de la ponction biopsie hépatique. Gastroenterol Clin Biol. 2002; 26: 848-78.
[20]
General principles. In: Lee RG. Diagnostic liver pathology. St. Louis: Mosby–Year Book, 1994: 1-21.
[21]
Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol. 1980; 15: 329-35.
[22]
Sporea I, Popescu A, Sirli R. Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol. 2008; 14 (21): 3396-402.
[23]
Baunsgaard P, Sanchez GC, Lundborg CJ. The variation of pathological changes in the liver evaluated by double biopsies. ActaPatholMicrobiolImmunol Scand. 1979; 87: 51-7.
[24]
Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology. Gut1999; 45 Suppl 4: IV1-IV11.
[25]
Borzio M, Borzio F, Macchi R, Croce AM, Bruno S, Ferrari A, et al. The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis. J Hepatol. 1994; 20: 117-21.
[26]
Spycher C, Zimmermann A, Reichen J. The diagnostic value of liver biopsy. BMC Gastroenterol. 2001; 1: 1.
[27]
Farrell RJ, Smiddy PF, Pilkington RM, Tobin AA, Mooney EE, Temperley IJ, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. J Hepatol. 1999; 30: 580-7.
[28]
Papini E, Pacella CM, Rossi Z, Bizzarri G, Fabbrini R, Nardi F, et al. A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. J Hepatol. 1991; 13: 291-7.
[29]
Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, et al. The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy. Hepatology. 1996; 23: 1079-83.
[30]
Minuk G, Sutherland L, Wiseman D, MacDonald F, Ding D. Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bed rest after percutaneous liver biopsy. Gastroenterology. 1987; 92: 290-3.
[31]
Boyum JH, Atwell TD, Schmit GD, Poterucha JJ, Schleck CD, Harmsen WS. Incidence and Risk Factors for Adverse Events Related to Image-Guided Liver Biopsy. Mayo Clin Proc. 2016 Mar; 91 (3): 329-35.
[32]
Caturelli E, Giacobbe A, Facciorusso D, Bisceglia M, Villani MR, Siena DA, et al. Percutaneous biopsy in diffuse liver disease: increasing diagnostic yield and decreasing complication rate by routine ultrasound assessment of puncture site. Am J Gastroenterol. 1996; 91.
Browse journals by subject